Literature DB >> 20398589

Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease.

Hashem El-Serag1, Katherine A McGlynn, Garth N Graham, Samuel So, Charles D Howell, Ted Fang, Janelle Tangonan Anderson, Thelma King Thiel.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20398589      PMCID： PMC4550292     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  23 in total

1.  Disparity in use of orthotopic liver transplantation among blacks and whites.

Authors:  Andrea E Reid; Maria Resnick; YuChiao Chang; Nathan Buerstatte; Joel S Weissman
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

2.  Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.

Authors:  Dana Sloane; Hegang Chen; Charles Howell
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

3.  Rate and predictors of treatment prescription for hepatitis C.

Authors:  Adeel A Butt; Amy C Justice; Melissa Skanderson; Michael O Rigsby; Chester B Good; C Kent Kwoh
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

4.  Epidemiology of hepatocellular carcinoma in USA.

Authors:  Hashem B El-Serag
Journal:  Hepatol Res       Date:  2007-09       Impact factor: 4.288

5.  Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.

Authors:  Maribel Rodriguez-Torres; Lennox J Jeffers; Muhammad Y Sheikh; Lorenzo Rossaro; Victor Ankoma-Sey; Fayez M Hamzeh; Paul Martin
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

6.  Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.

Authors:  Yvonne N Flores; Hal F Yee; Mei Leng; José J Escarce; Roshan Bastani; Jorge Salmerón; Leo S Morales
Journal:  Am J Gastroenterol       Date:  2008-07-30       Impact factor: 10.864

7.  Public health model for prevention of liver cancer among Asian Americans.

Authors:  Hee-Soon Juon; Carol Strong; Thomas H Oh; Theresa Castillo; Grace Tsai; Leslie D Hsu Oh
Journal:  J Community Health       Date:  2008-08

8.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

9.  Disparities in liver transplantation before and after introduction of the MELD score.

Authors:  Cynthia A Moylan; Carla W Brady; Jeffrey L Johnson; Alastair D Smith; Janet E Tuttle-Newhall; Andrew J Muir
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

10.  Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

Authors:  Matthew Wise; Stephanie Bialek; Lyn Finelli; Beth P Bell; Frank Sorvillo
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425
View more
  8 in total

1.  Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.

Authors:  Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

2.  Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers.

Authors:  Nizar A Mukhtar; Priya Kathpalia; Joan F Hilton; Gene Lau; Albert Yu; Kevin Grumbach; Tung T Nguyen; Daniel Chan; Mandana Khalili
Journal:  J Clin Gastroenterol       Date:  2017-08       Impact factor: 3.062

3.  Viral Hepatitis Among African Immigrants with Hepatocellular Carcinoma in Minnesota: High Prevalence Yet Low Awareness.

Authors:  Prowpanga Udompap; Carlos G Moscoso; Chimaobi Anugwom; Mandip Kc; Nicholas Lim; John Lake; Mohamed Hassan
Journal:  J Immigr Minor Health       Date:  2022-09-15

4.  Race and ethnicity do not impact eligibility for remdesivir: A single-center experience.

Authors:  Lauren Pischel; Makeda Walelo; Jemma Benson; Rebecca Osborn; Rachel Schrier; Jessica Tuan; Lydia Barakat; Onyema Ogbuagu
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

5.  Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.

Authors:  Amelie G Ramirez; Nancy S Weiss; Alan E C Holden; Lucina Suarez; Sharon P Cooper; Edgar Munoz; Susan L Naylor
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

6.  Determinants of stigma among patients with hepatitis C virus infection.

Authors:  M Elle Saine; Julia E Szymczak; Tyler M Moore; Laura P Bamford; Frances K Barg; Jason Schnittker; John H Holmes; Nandita Mitra; Vincent Lo Re
Journal:  J Viral Hepat       Date:  2020-06-23       Impact factor: 3.517

7.  The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010-2016.

Authors:  Bernard Luke Edmunds; Emma Ruth Miller; George Tsourtos
Journal:  BMC Public Health       Date:  2019-05-08       Impact factor: 3.295

8.  Sociocultural barriers to hepatitis B health literacy in an immigrant population: a focus group study in Korean Americans.

Authors:  Sarah Hyun; Okhyun Ko; Soonsik Kim; William R Ventura
Journal:  BMC Public Health       Date:  2021-02-25       Impact factor: 3.295
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.